Sort
34,240 grants matching “atherosclerosis”
Neurobiological pathways linking stress and emotion to atherosclerosis
$503,368Peter J Gianaros · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · HL
Genotoxic Stress, Atherosclerosis and Metabolic Syndrome
$503,311Clay F. Semenkovich · Washington University · P50 · FY2009 · HL
Diabetes Prevention Program Outcomes Study - Phase 2
$503,174Richard F Hamman · University Of Colorado Denver · U01 · FY2009 · DK
Iron and Atherosclerosis
$503,127Subha V Raman · Ohio State University · R01 · FY2009 · HL
Dicarbonyl Scavengers to Improve HDL Function and Reduce Atherosclerosis in FH
$503,016Macrae F Linton · Vanderbilt University Medical Center · P01 · FY2023 · HL
Role of innate immunity in HIV related vascular disease: biomarkers & mechanisms
$503,014Robert C Kaplan · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · HL
ENDOTHELIAL MODIFICATIONS THAT REDUCE T CELL ACTIVATION
$502,969Yale University · R01 · FY2004 · HL
Targeted Mitochondrial Delivery Systems for Vascular Interventions
$502,949Bin Jiang · Northwestern University At Chicago · R56 · FY2023 · HL
Long non-coding RNA-mediated chromatin remodeling in angiogenesis
$502,935Zhen Bouman Chen · Beckman Research Institute/City Of Hope · R01 · FY2020 · HL
Developing High-Resolution Ion Mobility Spectrometry-Charge Detection-Mass Spectrometry for Rapid Analysis in the Megadalton to Gigadalton Regime
$502,870Martin F Jarrold · Trustees Of Indiana University · R01 · FY2022 · GM
Systemic Endothelial Consequences of Periodontal Disease
$502,804Salomon Amar · Boston University Medical Campus · R01 · FY2008 · DE
Genetics Myocardial Adverse Outcomes/Graft Failure-CABG
$502,770Mihai Victor Podgoreanu · Duke University · R01 · FY2008 · HL
ABCA1/G1 and LXRs in Atherogenesis
$502,605Alan Richard Tall · Columbia University Health Sciences · R01 · FY2022 · HL
Mechanisms Mediating Enhanced Sympatho-Activation During Exercise in Hypertension
$502,574Donal S. O'Leary · Wayne State University · R01 · FY2019 · HL
RANK-RANKL and Vascular Complications in Chronic Kidney Disease
$502,545Michael E Rosenfeld · University Of Washington · R01 · FY2015 · DK
RANK-RANKL and Vascular Complications in Chronic Kidney Disease
$502,545Michael E Rosenfeld · University Of Washington · R01 · FY2014 · DK
RANK-RANKL and Vascular Complications in Chronic Kidney Disease
$502,545Michael E Rosenfeld · University Of Washington · R01 · FY2016 · DK
Genetic Regulation of Phospholipid Synthesis in Yeast
$502,485Susan A. Henry · Cornell University · R01 · FY2010 · GM
Cardiovascular Epidemiology Training Grant
$502,463Wayne D. Rosamond · Univ Of North Carolina Chapel Hill · T32 · FY2020 · HL
Synthetic Counter-ligands for Inhibition of Atherosclerosis
$502,386Prabhas V Moghe · Rutgers, The State Univ Of N.J. · R01 · FY2013 · HL
Oxidized Lipids and Endotoxemia in Vascular Inflammation
$502,328Yury Miller · La Jolla Institute For Immunology · P01 · FY2012 · HL
Developmental Determinants of Cardiovascular Disease
$502,321H. Scott Baldwin · Vanderbilt University Medical Center · T32 · FY2018 · HL
Modulation of Hepcidin-Ferroportin Signaling using Small Molecules
$502,260Donald B Bloch · Massachusetts General Hospital · R01 · FY2017 · DK
Modulation of Hepcidin-Ferroportin Signaling using Small Molecules
$502,260Donald B Bloch · Massachusetts General Hospital · R01 · FY2018 · DK
Modulation of Hepcidin-Ferroportin Signaling using Small Molecules
$502,260Randall T Peterson · Massachusetts General Hospital · R01 · FY2015 · DK